Abstract:Established tumors build a stressful and hostile microenvironment that blocks the development of protective innate and adaptive immune responses. Different subsets of immunoregulatory myeloid populations, including dendritic cells, myeloid-derived suppressor cells (MDSCs) and macrophages, accumulate in the stressed tumor milieu and represent a major impediment to the success of various forms of cancer immunotherapy. Specific conditions and factors within tumor masses, including hypoxia, nutrient starvation, low pH, and increased levels of free radicals, provoke a state of “endoplasmic reticulum (ER) stress” in both malignant cells and infiltrating myeloid cells. In order to cope with ER stress, cancer cells and tumor-associated myeloid cells activate an integrated signaling pathway known as the Unfolded Protein Response (UPR), which promotes cell survival and adaptation under adverse environmental conditions. However, the UPR can also induce cell death under unresolved levels of ER stress. Three branches of the UPR have been described, including the activation of the inositol-requiring enzyme 1 (IRE1), the pancreatic ER kinase (PKR)-like ER kinase (PERK), and the activating transcription factor 6 (ATF6). In this minireview, we briefly discuss the role of ER stress and specific UPR mediators in tumor development, growth and metastasis. In addition, we describe how sustained ER stress responses operate as key mediators of chronic inflammation and immune suppression within tumors. Finally, we discuss multiple pharmacological approaches that overcome the immunosuppressive effect of the UPR in tumors, and that could potentially enhance the efficacy of cancer immunotherapies by reprogramming the function of tumor-infiltrating myeloid cells.

Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance

Endoplasmic Reticulum Stress Induced Autophagy in Cancer and Its Potential Interactions with Apoptosis and Ferroptosis.

Structural and Functional Significance of the Endoplasmic Reticulum Unfolded Protein Response Transducers and Chaperones at the Mitochondria–ER Contacts: A Cancer Perspective

Cancer Microenvironment and Endoplasmic Reticulum Stress Response

Interplay between unfolded protein response and autophagy promotes tumor drug resistance

The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance

Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response

Endoplasmic Reticulum Stress Pathway, the Unfolded Protein Response, Modulates Immune Function in the Tumor Microenvironment to Impact Tumor Progression and Therapeutic Response

Endoplasmic Reticulum Stress Regulates Tumor Growth and Anti-Tumor Immunity: a Promising Opportunity for Cancer Immunotherapy

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy

Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion

Endoplasmic Reticulum Stress Targeted Therapy for Breast Cancer

Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer

[A Review of the Roles of Endoplasmic Reticulum Stress in Cancer Cell Metastasis].

Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis

Endoplasmic Reticulum Stress in Melanoma Pathogenesis and Resistance

Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions

Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives

Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy

Endoplasmic Reticulum Stress, the Unfolded Protein Response, and Gene Network Modeling in Antiestrogen Resistant Breast Cancer.

Analysis on endoplasmic reticulum stress in the cancer cells